Aster Mental Health
Aster Mental Health is an outpatient psychiatric practice with offices in Braintree and Peabody, Massachusetts, plus telehealth. It is not a residential addiction-rehabilitation center.
Current services include therapy, psychiatric medication management, transcranial magnetic stimulation (TMS) and SPRAVATO treatment for eligible adults with treatment-resistant depression. Therapy sessions are about 55 minutes. The published TMS course is 36 sessions, typically 20–30 minutes per session, five weekdays per week; other treatment length is individualized.
Aster is in network with many commercial HMO and PPO plans, offers out-of-network paperwork, self-pay, payment plans and CareCredit, and is not contracted with MassHealth, Medicare or Medicaid. Coverage and patient cost depend on the service and plan.
Plan around outpatient appointments in Braintree or Peabody
Aster’s current contact page identifies two Massachusetts offices: Braintree and Peabody. Its administrative hours are Monday through Friday, 9 a.m. to 5 p.m. Weekend visits are by prior arrangement, while the administrative office is closed. A weekend appointment therefore should not be interpreted as unrestricted weekend reception or walk-in access.
The practice separates the intake route for prospective patients from scheduling and rescheduling for existing patients. Before choosing an office, confirm where the particular clinician or procedure is available, whether the initial visit must be in person, and how subsequent appointments will be arranged. This matters when a care plan combines remote therapy with procedures that require repeated attendance at an office.
Ask how messages are handled between visits and what arrangements apply outside administrative hours. Office contact information alone does not establish an emergency assessment service. Aster’s appointment model should be compared with other outpatient practices according to access, clinical fit, and continuity, rather than the accommodation features of a residential center.
The practice model emphasizes ongoing individual care
According to its practice overview, Aster opened in 2020 under psychiatrist Shahrzad Sims. It describes a multidisciplinary team of therapists and medication prescribers, longer appointments, limited therapist workloads, and a choice of virtual or office-based meetings. These are descriptions of how the practice organizes care, rather than promises of a specific appointment length with every clinician.
The overview names a broad range of concerns, including depression, anxiety, bipolar disorder, postpartum difficulties, PTSD, and schizophrenia. A list of conditions does not establish that every severity or current crisis can be managed in a routine outpatient appointment. An initial discussion should address present symptoms, previous treatment, other medical care, and whether another setting is needed alongside or before this service.
For someone changing practices, continuity is a useful practical question: who reviews prior records, whether an existing therapist can remain involved, and how the new clinician will communicate with other professionals with consent. Discussing those arrangements makes the practice’s personalized-care description more concrete.
Medication management involves assessment and follow-up
Aster’s medication-management page describes prescribing, monitoring response, reviewing tolerability, and adjusting a treatment plan. It offers in-person and online appointments and says prescriptions are sent to the patient’s preferred pharmacy. This is a clinical follow-up service; it does not mean that making an appointment guarantees a requested medication or an immediate prescription.
The page distinguishes medication prescribers from professionals whose primary role is counseling. It also allows for therapy and other approaches within the overall plan. A patient using both services should ask who coordinates the plan, how concerns about side effects are communicated, and when the next review will occur. Existing medication and treatment history should be discussed with the prescriber rather than changed independently to prepare for a visit.
Aster advertises that some new patients can be seen within 48 hours. Treat that as an availability statement to check for the required clinician and visit type, not a confirmed appointment. Ask about prescription-review arrangements when transferring care or traveling.
Therapy has its own goals, methods, and schedule
The therapy program describes sessions lasting approximately 55 minutes, either online or in person. The first meeting gathers information about symptoms, experiences, background, and goals; the therapist then discusses the proposed frequency and direction of treatment. The total course is individualized rather than sold as a fixed residential stay.
Listed approaches include cognitive behavioral therapy, dialectical behavioral therapy, acceptance and commitment therapy, trauma-informed work, motivational interviewing, and exposure and response prevention. Other methods include narrative, movement, play, and solution-focused therapy. This range does not mean one clinician provides every approach or that all methods are equally suited to every concern.
Ask which approach the proposed therapist uses for the presenting problem, how progress will be reviewed, and whether any between-session work is expected. If a page mentions play therapy or another age-specific method, confirm the particular clinician’s age criteria directly. Choosing a named approach should follow the assessment and the patient’s goals, rather than a general list of techniques.
TMS requires a repeated office-based treatment course
Aster’s TMS page describes NeuroStar treatment at Braintree and Peabody. Its published schedule is 36 sessions, generally lasting 20–30 minutes, on five weekdays per week. Consultation, assessment, and scheduling still determine the individual plan. Consider the repeated travel and work arrangements before comparing this service with occasional therapy appointments.
The treatment is delivered while the patient is awake, without sedation or anesthesia. The provider lists headache and scalp discomfort among possible side effects. It positions TMS for assessment after other depression treatments have been ineffective or poorly tolerated. Its published outcome percentages should not be interpreted as an individual prognosis or as results independently established for every Aster patient.
The FAQ discusses device clearance for younger patients, but that does not establish acceptance for every age, diagnosis, or treatment protocol at this practice. Confirm clinical eligibility, the proposed device protocol, insurance authorization, and how response will be evaluated. Continue discussing medication decisions with the treating clinician.
SPRAVATO appointments include monitoring and transportation planning
The SPRAVATO program is described for eligible adults with treatment-resistant depression. Aster outlines an initial twice-weekly schedule for four weeks, followed by a physician’s review of whether treatment should continue and at what frequency. This is an assessed course of care, not a guaranteed four-week solution or a self-administered treatment to take home.
The practice says patients remain under observation for at least two hours after administration. It also requires planning for transportation because driving and other activities requiring full alertness are restricted after treatment. Obtain the team’s complete instructions when arranging work, caregiving, travel, and the return journey.
Aster lists potentially serious risks as well as more common adverse effects and describes reviewing medical history before acceptance. The consultation should cover those risks, other medicines, relevant medical conditions, and what happens if treatment is unsuitable or ineffective. Published remission figures and promotional descriptions do not replace that discussion. Insurance approval and the ability to attend monitoring visits are separate practical requirements.
Ask which professional will provide each part of care
Aster’s prescriber directory lists psychiatrists, a psychiatric nurse practitioner, and a physician assistant. The directory identifies Shahrzad Sims as Chief Medical Officer. It is useful for understanding the practice’s professional mix, but it does not establish which person will accept a particular referral or attend every appointment.
When arranging care, ask who will conduct the initial evaluation, who handles routine follow-up, and whether the same professional will remain involved over time. If therapy is also recommended, clarify whether it is a separate appointment and how information will be shared between clinicians with permission. Different professional roles should be explained before the patient commits to a schedule.
A directory entry is also distinct from a confirmed match for a specific age group, clinical problem, or procedure. Confirm the proposed professional’s relevant experience and current availability directly. If a clinician is away, ask how coverage and time-sensitive medication questions are handled without assuming that every listed team member provides interchangeable care.
Insurance participation still requires a service-specific check
The insurance information states that Aster participates in many commercial HMO and PPO plans. It expressly says the practice is not contracted with MassHealth, Medicare, or Medicaid. That distinction should be resolved early for anyone relying on one of those public programs.
For participating plans, Aster says it submits claims after visits. For out-of-network patients, it can provide paperwork for the insurer to consider reimbursement. Such paperwork does not guarantee payment, and a plan’s general mental health benefits do not establish that every clinician, procedure, or course is authorized.
Ask the practice and insurer to confirm the specific provider, location, proposed service, and expected patient responsibility. Therapy, medication-management visits, procedures, and pharmacy costs may need separate questions rather than one assumption that the entire plan is covered. If using out-of-network benefits, understand what must be paid initially and who submits the claim. Retain the written estimate and authorization information when comparing options.
Request an estimate for the actual combination of services
Aster’s cost-of-care overview identifies self-pay, discussion of financial assistance, payment arrangements over time, insurance, and online bill payment. It invites patients needing financial help to contact the team. The page does not turn those options into a universal discount, automatic assistance award, or one price for all care.
A useful estimate identifies the initial assessment, planned follow-up frequency, and any separate procedure appointments. If more than one clinician is involved, clarify whether charges are separate. For a repeated treatment course, ask how reassessment, missed appointments, an early stop, or a change in schedule affects the anticipated total.
Discuss the terms of any practice payment plan before beginning, including when charges are due and how changes will be communicated. Patients already in care can use the portal for bills, but the portal itself does not explain the clinical scope or replace a written financial discussion. Compare costs using the same proposed services and time period.
CareCredit is a separate financial product
The CareCredit information describes an independent health and wellness credit card that may be used for eligible out-of-pocket treatment expenses. Aster identifies uses such as deductibles, copayments, and services not fully covered by insurance. The practice expressly states that it does not own or operate CareCredit.
Using credit is different from receiving an insurance benefit or a reduction in the treatment charge. Before choosing this route, request the actual amount to be financed and review the lender’s current terms, eligibility requirements, repayment schedule, and any promotional conditions. Do not assume that approval is automatic or that a promotional offer applies to every account or purchase.
It is also reasonable to ask the practice about its own payment arrangements or assistance discussion before selecting financing. Keep the clinical decision separate: having a way to pay does not establish that a procedure is appropriate, and a treatment recommendation does not determine which financial option is suitable for the patient.
Provider sources reviewed October 19, 2026. Confirm current program availability, clinical eligibility, fees, and insurance arrangements directly.
Official sources
Sources checked October 13, 2026.
